Therapeutic area intelligence for Microbiota Therapy with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 0
Companies: 1

Companies

MTP-101P →

Assets

Phase →

Recent signals(1)

ClinicalJuly 3, 2026

Phase 1 Trial of MTP-101P for Safety in Colon Resection Patients

A Phase 1 pilot trial is underway to assess the safety and feasibility of MTP-101P in patients undergoing colon resection.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.